1. Immunohistochemical features of canine ovarian papillary adenocarcinoma and utility of cell block technique for detecting neoplastic cells in body cavity effusions.
- Author
-
Kita C, Chambers JK, Tanabe M, Irie M, Yamasaki H, and Uchida K
- Subjects
- Animals, Biomarkers, Tumor metabolism, Diagnosis, Differential, Dogs, Immunohistochemistry, Adenocarcinoma, Papillary diagnosis, Adenocarcinoma, Papillary veterinary, Dog Diseases diagnosis, Dog Diseases pathology, Kidney Neoplasms veterinary, Ovarian Neoplasms diagnosis, Ovarian Neoplasms veterinary, Pleural Effusion, Malignant diagnosis, Pleural Effusion, Malignant metabolism, Pleural Effusion, Malignant pathology, Pleural Effusion, Malignant veterinary
- Abstract
Dogs with ovarian papillary adenocarcinoma occasionally present with ascites and/or pleural effusion. These aspirated fluids often contain a large number of cells, and distinction between neoplastic cells and activated mesothelial cells can be difficult. In this study, 7 cases of canine ovarian papillary adenocarcinoma, including 3 with ascites and pleural effusion, were immunohistochemically examined. Ovarian tumor cells were positive for cytokeratin CAM5.2 (CAM5.2), Wilms' tumor 1 (WT-1) and progesterone receptor (PR) in all 7 cases. A metastatic lesion of the mediastinum in one case was also positive for CAM5.2, WT-1 and PR. Immunohistochemistry on cell blocks obtained from ascites and/or pleural effusion of 2 cases revealed the presence of PR-positive epithelial cells. Whereas, activated mesothelial cells in ascites or pleural effusion collected from dogs without neoplastic lesions were negative for PR. In addition, surface epithelium and subsurface epithelial structures (SES) of normal canine ovaries, that are considered to be the cell of origin for ovarian papillary adenocarcinoma, were also positive for CAM5.2, WT-1 and PR. These results indicate that, together with CAM5.2, WT-1 and PR is a useful diagnostic marker for canine ovarian papillary adenocarcinoma. Expression of PR may be associated with progesterone-dependent nature of canine ovarian papillary adenocarcinoma.
- Published
- 2022
- Full Text
- View/download PDF